封面
市场调查报告书
商品编码
1630720

药物依从性市场规模、份额、成长分析,按产品类型、按剂量类型、按交付方式、按最终用户、按地区 - 行业预测,2025 年至 2032 年

Medication Adherence Market Size, Share, Growth Analysis, By Product Type (Hardware, Software), By Medication Type (Cardiovascular Drugs, Diabetes Drugs), By Delivery Mode, By End-User, By Region - Industry Forecast 2025-2032

出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格
简介目录

预计 2023 年药物依从性市场规模将达到 45 亿美元,并从 2024 年的 52 亿美元成长到 2032 年的 164.6 亿美元,预测期内(2025-2032 年)的复合年增长率为 15.5%。

全球药物依从性市场正在经历显着扩张,这得益于对以患者为中心的护理的日益关注、慢性病患病率的上升以及医疗技术的进步。持续存在的服药依从性差的挑战会导致治疗效果不佳和医疗成本高昂。为了解决这一重大问题,越来越多旨在提高药物依从率的创新解决方案和技术正在出现。这种积极主动的方法不仅可以解决依从性难题,还可以推动全球药物依从性市场的整体成长,预示着患者参与度和健康状况的提高的美好未来。

目录

介绍

  • 调查目的
  • 研究范围
  • 定义

调查方法

  • 资讯采购
  • 次要和资料资料
  • 市场规模预测
  • 市场假设与限制

执行摘要

  • 全球市场展望
  • 供需趋势分析
  • 细分市场机会分析

市场动态及展望

  • 市场概况
  • 市场规模
  • 市场动态
    • 驱动因素和机会
    • 限制与挑战
  • 波特的分析

主要市场考察

  • 关键成功因素
  • 竞争程度
  • 主要投资机会
  • 市场生态系统
  • 市场吸引力指数(2024 年)
  • PESTEL 分析
  • 总体经济指标
  • 价值链分析
  • 定价分析
  • 案例研究
  • 监管格局
  • 专利分析

药物依从性市场规模(依产品类型)

  • 市场概况
  • 硬体
    • 智慧药瓶
    • 智慧锭剂分配器
    • 电子药品包
  • 软体
    • 药物管理应用程式
    • 电子健康记录 (EHR) 集成
  • 服务
    • 药物治疗管理
    • 病患教育和培训

药物依从性市场规模(依药物类型)

  • 市场概况
  • 心血管药物
  • 糖尿病药物
  • 呼吸系统药物
  • 中枢神经系统 (CNS) 药物
  • 肿瘤药物
  • 其他的

药物依从性市场规模(以交付方式)

  • 市场概况
  • 本地
  • 云端基础

药物依从性市场规模(以最终用户划分)

  • 市场概况
  • 医院
  • 药局
  • 家庭医疗保健
  • 研究组织
  • 其他的

药物依从性市场规模

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 义大利
    • 其他欧洲国家地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲国家
  • 中东和非洲
    • 海湾合作委员会国家
    • 南非
    • 其他中东和非洲地区

竞争资讯

  • 前 5 家公司对比
  • 主要企业市场定位(2024年)
  • 主要市场参与者所采用的策略
  • 近期市场趋势
  • 公司市场占有率分析(2024 年)
  • 主要企业简介
    • 公司简介
    • 产品系列分析
    • 按细分市场分析市场份额
    • 收益与前一年同期比较(2022-2024 年)

主要企业简介

  • Omnicell, Inc.(United States)
  • Koninklijke Philips NV(Netherlands)
  • Medtronic plc(Ireland)
  • McKesson Corporation(United States)
  • Cerner Corporation(United States)
  • Becton, Dickinson and Company(United States)
  • Johnson & Johnson Services, Inc.(United States)
  • Novartis International AG(Switzerland)
  • Siemens Healthineers AG(Germany)
  • AdhereTech Inc.(United States)
  • SMRxT Inc.(United States)
  • Pillsy Inc.(United States)
  • TruMed Systems Inc.(United States)
  • Proteus Digital Health(United States)
  • Allscripts Healthcare Solutions, Inc.(United States)
  • MedMinder(United States)
  • Caredose(United States)
  • PHC Holdings Corporation(Japan)
  • Kakehashi Inc.(Japan)

结论和建议

简介目录
Product Code: SQMIG35F2015

Global Medication Adherence Market size was valued at USD 4.5 billion in 2023 and is poised to grow from USD 5.2 billion in 2024 to USD 16.46 billion by 2032, growing at a CAGR of 15.5% during the forecast period (2025-2032).

The global medication adherence market is experiencing significant expansion, fueled by a heightened emphasis on patient-centric care, a growing incidence of chronic diseases, and advancements in healthcare technology. The ongoing challenge of poor medication adherence has resulted in ineffective treatment outcomes and escalating healthcare costs. In response to this critical issue, an array of innovative solutions and technologies has emerged, aimed at enhancing medication adherence rates. This proactive approach not only addresses the adherence dilemma but also propels the overall growth of the global medication adherence market, indicating a promising future driven by patient engagement and improved health outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Medication Adherence market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Medication Adherence Market Segmental Analysis

Global Medication Adherence Market is segmented by Product Type, Medication Type, Delivery Mode, End-User and region. Based on Product Type, the market is segmented into Hardware, Software and Services. Based on Medication Type, the market is segmented into Cardiovascular Drugs, Diabetes Drugs, Respiratory Drugs, Central Nervous System (CNS) Drugs, Oncology Drugs and Others. Based on Delivery Mode, the market is segmented into On-Premise and Cloud-Based. Based on End-User, the market is segmented into Hospitals, Pharmacies, Home Healthcare, Research Institutes and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Medication Adherence Market

The Global Medication Adherence market is being significantly propelled by the rising burden of chronic diseases, including diabetes, cardiovascular conditions, respiratory disorders, and cancer. As these conditions become more prevalent, the need for effective long-term medication adherence strategies intensifies to ensure optimal treatment outcomes and enhance patient health. The aging population, which is particularly vulnerable to chronic illnesses and often requires multiple medications for effective disease management, further amplifies this demand. Medication adherence solutions are essential in assisting older adults in managing their medication schedules effectively, thereby reducing the risk of complications associated with improper medication use and improving overall health outcomes.

Restraints in the Global Medication Adherence Market

The Global Medication Adherence market faces significant restraints, particularly due to apprehensions surrounding privacy and data security. With the increasing integration of digital health technologies in medication adherence solutions, there are growing concerns regarding the safeguarding of patient information. Healthcare providers and solution developers must prioritize these issues, as they are crucial for fostering trust and maintaining patient confidentiality. Addressing these concerns is essential to ensure the successful implementation and adoption of medication adherence solutions, as any breach or perception of insecurity could hinder market growth and patient cooperation in adhering to treatment plans.

Market Trends of the Global Medication Adherence Market

The Global Medication Adherence market is experiencing a notable trend towards remote patient monitoring, driven by the surge in telehealth services. The COVID-19 pandemic accelerated the adoption of virtual healthcare, making it crucial for healthcare providers to ensure patient compliance with medication regimens. Advanced technologies, including mobile apps and wearables, enable healthcare professionals to monitor adherence in real-time and deliver timely interventions or reminders, thereby enhancing patient outcomes. As healthcare systems increasingly prioritize patient engagement and outcomes, the integration of remote monitoring solutions is expected to reshape the medication adherence landscape, fostering a more proactive and personalized approach to patient care.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Case Studies
  • Regulatory Landscape
  • Patent Analysis

Global Medication Adherence Market Size by Product Type & CAGR (2025-2032)

  • Market Overview
  • Hardware
    • Smart Pill Bottles
    • Smart Pill Dispensers
    • Electronic Medication Packaging
  • Software
    • Medication Management Apps
    • Electronic Health Records (EHR) Integration
  • Services
    • Medication Therapy Management
    • Patient Education & Training

Global Medication Adherence Market Size by Medication Type & CAGR (2025-2032)

  • Market Overview
  • Cardiovascular Drugs
  • Diabetes Drugs
  • Respiratory Drugs
  • Central Nervous System (CNS) Drugs
  • Oncology Drugs
  • Others

Global Medication Adherence Market Size by Delivery Mode & CAGR (2025-2032)

  • Market Overview
  • On-Premise
  • Cloud-Based

Global Medication Adherence Market Size by End-User & CAGR (2025-2032)

  • Market Overview
  • Hospitals
  • Pharmacies
  • Home Healthcare
  • Research Institutes
  • Others

Global Medication Adherence Market Size & CAGR (2025-2032)

  • North America (Product Type, Medication Type, Delivery Mode, End-User)
    • US
    • Canada
  • Europe (Product Type, Medication Type, Delivery Mode, End-User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product Type, Medication Type, Delivery Mode, End-User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product Type, Medication Type, Delivery Mode, End-User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product Type, Medication Type, Delivery Mode, End-User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Omnicell, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Koninklijke Philips N.V. (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic plc (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • McKesson Corporation (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cerner Corporation (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Becton, Dickinson and Company (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Johnson & Johnson Services, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Novartis International AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Siemens Healthineers AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AdhereTech Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • SMRxT Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pillsy Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • TruMed Systems Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Proteus Digital Health (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Allscripts Healthcare Solutions, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MedMinder (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Caredose (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PHC Holdings Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Kakehashi Inc. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations